Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

ELREXFIO vs SARCLISA ESCENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Possible drug interaction. ELREXFIO and SARCLISA ESCENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

elrexfiosarclisa escena

Rating

60/100
72/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

ELRANATAMAB
ISATUXIMAB-IRFC

Manufacturer

Pfizer
Sanofi-Aventis U.S. LLC

Dosage forms

Injectable
Injectable

Drug class

—
—

Boxed warning

Boxed warning
None

Treats

Multiple Myeloma
Multiple Myeloma

Frequently asked questions

Which is better-rated, Elrexfio or Sarclisa Escena?

By our independent rating, Sarclisa Escena scores higher — 3.6 vs 3.0 out of 5 for Elrexfio. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Elrexfio and Sarclisa Escena?

Elrexfio contains Elranatamab, while Sarclisa Escena contains Isatuximab-Irfc — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.